Hyderabad Telangana, India

Srinivasa Rao Potla

This inventor holds 1 USPTO granted patent. Top assignee: Mylan Laboratories Limited. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Srinivasa Rao Potla. Retrieved from https://idiyas.com/inventor/srinivasa-rao-potla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Srinivasa Rao Potla

Introduction

Srinivasa Rao Potla is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug synthesis. His work exemplifies the intersection of science and technology in addressing medical needs.

Latest Patents

Srinivasa Rao Potla holds a patent for the synthesis of Aliskiren. This invention provides a novel process for the preparation of the renin inhibitor Aliskiren and its derivatives, along with its pharmaceutically acceptable salts. The patent also details novel intermediates used in the preparation of Aliskiren, showcasing his expertise in pharmaceutical chemistry.

Career Highlights

He is currently associated with Mylan Laboratories Limited, a leading global pharmaceutical company. His role at Mylan has allowed him to contribute to the development of important medications that can improve patient outcomes. His dedication to innovation in drug synthesis is evident in his work.

Collaborations

Srinivasa Rao Potla has collaborated with notable colleagues such as Rama Shankar and Vadali Lakshmana Rao. These collaborations have likely enhanced the scope and impact of his research and inventions.

Conclusion

Srinivasa Rao Potla's contributions to the field of pharmaceuticals through his innovative patent for Aliskiren synthesis highlight his role as a significant inventor. His work continues to influence the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…